Leadership Team

The Leadership Team at Clene Nanomedicine is responsible for setting the strategic direction of the company and overseeing the development of innovative therapeutics for neurodegenerative diseases. Comprising key executives such as the Chief Science Officer and Chief Development Officer, the team drives research initiatives, manages operational activities, and ensures financial stability, all while fostering collaboration to advance clinical programs and bring groundbreaking solutions to market.